Last updated: April 25, 2026
Twinject (epinephrine injection) suppliers: who manufactures and supplies the product?
Twinject is a brand of epinephrine injection for emergency treatment of severe allergic reactions (anaphylaxis). In the US market, Twinject is supplied through the product’s market authorization holder/manufacturer chain, with subcontracting and labeler roles varying by country and distribution channel.
What supplier identities apply to Twinject?
The supplier footprint for Twinject typically breaks into four operational tiers:
-
Finished-dose manufacturer (drug product site)
Manufactures and packages the ready-to-use injector (drug product).
-
Active ingredient and sterile component suppliers
Provide epinephrine and sterile-filled components used for final drug product assembly (upstream manufacturing).
-
Device and assembly partner(s)
Provides injector mechanism, cartridge/ampoule components, and assembly steps when the autoinjector is produced via a device supply chain.
-
Market authorization holder / labeler and distributor
Controls product registration and arranges distribution in-country, even when manufacturing is performed by a separate finished-dose plant.
Who is the known commercial supplier for Twinject in the US?
For Twinject in the US, the product has been marketed under the following branded supplier relationships (brand/labeler context):
| Role |
Supplier identity |
Evidence |
| US labeler / holder for Twinject epinephrine injection |
Pfizer |
Twinject branding and product listing context in US regulatory and commercial references that track the brand’s marketing and label history (product monograph / listings). |
What manufacturer supply chain is tied to the autoinjector build?
Twinject is an injector product, so device/assembly suppliers are part of the operational supply chain. However, supplier-by-supplier identification (device subcomponents, sterilization subcontractors, and specific sterile fill-finish site names) is not consistently disclosed at the brand level in public listings.
For investment-grade supplier mapping, the only consistently provable public path is:
- US FDA product labeling and registered facilities tied to the application, and/or
- country-specific regulatory dossiers and manufacturing site declarations.
Public brand pages usually confirm the labeler rather than the full vendor roster behind the autoinjector device and the sterile fill-finish operations.
Practical supplier mapping for diligence (Twinject)
Use the following supplier map logic to translate public label/registration facts into a vendor list for commercial contracting and R&D diligence:
A. Confirm finished-dose manufacturer(s)
- Target: the drug product manufacturing site listed in product registration and labeling-linked facility references.
- Output: one or more finished-dose plants.
B. Confirm sterile fill-finish responsibility
- Target: the sterile fill-finish step site(s) tied to the injector manufacturing record.
- Output: one or more sterile manufacturing sites.
C. Confirm device/assembly work share
- Target: the injector mechanism and assembly partner that supplies device hardware steps.
- Output: device supplier(s) (autoinjector components), plus assembly subcontractor(s) if separate from drug product manufacturing.
D. Confirm active pharmaceutical ingredient (API) sourcing
- Target: epinephrine API source and any conversion steps tied to the product dossier.
- Output: API supplier(s) and potentially intermediate supplier(s) if disclosed in the registration history.
Supplier landscape: what is typically discoverable vs. what is not
| Supplier layer |
Publicly discoverable with high confidence |
Often undisclosed at brand level |
| Labeler / market authorization holder |
Yes |
No |
| Finished-dose manufacturing site |
Sometimes, via regulatory facility links |
Sometimes |
| Sterile fill-finish subcontractor |
Sometimes, via facility-linked records |
Often |
| Injector device subcomponent suppliers |
Sometimes via device supplier disclosures |
Often |
| API supplier details |
Limited in public brand listings |
Frequently |
Actionable shortlist (who to approach first)
Given the limited brand-level disclosure in public-facing sources, the actionable first-round supplier list for Twinject supplier qualification typically prioritizes:
- Finished-dose manufacturer(s) of Twinject in the relevant geography (drug product site).
- Sterile fill-finish site(s) for injector manufacturing.
- Injector device / assembly supplier(s) supplying the autoinjector components and assembly steps.
- API supply chain for epinephrine used in Twinject drug product.
Key contract/quality diligence points for Twinject suppliers
For any qualified supplier, the diligence should center on:
- Sterility assurance and aseptic process control (injector drug product assembly)
- Container closure integrity for epinephrine in the injector system
- Dose accuracy and deliverable volume at scale (autoinjector delivery performance)
- Device reliability (actuation force, needle deployment performance, fraction filled verification)
- Change control covering formulation, fill-finish, device components, and labeling changes
- Regulatory alignment to local approvals for anaphylaxis use labeling
Key Takeaways
- Twinject supplier identification in public sources is strongest for the US labeler/marketed brand supplier, with Pfizer as the identifiable brand/labeler in mainstream US product references.
- A complete end-to-end supplier roster (API, sterile fill-finish subcontractors, injector device component suppliers) usually requires facility-linked regulatory records and application dossier manufacturing site declarations rather than brand marketing pages.
- The highest-value diligence ordering is: finished-dose manufacturer → sterile fill-finish site → injector device/assembly partner → epinephrine API source.
FAQs
Who supplies Twinject in the US market?
Pfizer is the identifiable US labeler/brand supplier in public product listings tied to Twinject.
Does Twinject use an autoinjector device with device suppliers?
Yes. Twinject is an injector product, so the supply chain includes injector device components and assembly steps performed by device/assembly partners in many manufacturing models.
Are API epinephrine suppliers publicly listed for Twinject?
Brand-level public sources often do not provide full API supplier identity; epinephrine API sourcing is commonly disclosed only in detailed regulatory dossiers and manufacturing documentation.
How do I identify the exact finished-dose plant for Twinject?
Use the facility/manufacturer references linked to the approved product in regulatory and labeling records rather than general brand pages.
What supplier capabilities matter most for Twinject manufacturing?
The critical capabilities are aseptic/sterile manufacturing, container closure integrity, dose accuracy, and autoinjector performance qualification.
References (APA)
[1] US FDA. (n.d.). Drug product information and labeling references for epinephrine injection, Twinject (product and label-linked references). https://www.accessdata.fda.gov/
